Updated Stability for Reconstituted and Diluted Solutions of KEYTRUDA® (pembrolizumab)

This post is part of CAPhO’s Email Distribution Service on behalf of Merck Canada Inc. and is not an endorsement or recommendation of the product or message content.

Please note that the storage conditions for reconstituted and diluted solutions of KEYTRUDA® have been updated:

“The product does not contain preservative. The reconstituted and/or diluted product should be used immediately. If not used immediately, reconstituted and diluted solutions of KEYTRUDA® may be stored at room temperature for a cumulative time of up to 6 hours. Reconstituted and diluted solutions of KEYTRUDA® may also be stored under refrigeration at 2°C to 8°C; however, the total time from reconstitution or dilution of KEYTRUDA® to completion of infusion should not exceed 96 hours. If refrigerated, allow the vials and/or IV bags to come to room temperature prior to use.”

Should you have any medical questions, please call Merck Canada’s Medical Information Centre at
1-800-567-2594.